東土科技(300353.SZ):將通過加大核心技術和芯片的自主可控,進一步擴大市場佔有率
格隆匯5月10日丨有投資者在投資者互動平台向東土科技(300353.SZ)提問,“2022年報顯示,公司的工業級網絡通信產品毛利率為43.23%,而同行公司三旺通信的工業交換產品毛利率超過61%,相差近20個點。請問較大差距的主要原因是什麼?”
東土科技回覆稱,工業網絡通信產品面向電力、軌交、石化、水利、智能製造、礦山等多個行業,不同行業競爭格局存在較大差異,公司不同系列產品的毛利率不等,作為國內工業和防務網絡市場領先企業,因市場覆蓋面較廣,整體毛利率水平處於行業綜合平均水平。公司將通過加大核心技術和芯片的自主可控,進一步擴大市場佔有率,提高盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.